Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2841 - 2848 of 12144 results

USCIS Conducts Third H-1B Cap Lottery
November 22, 2021| Alert| Viewpoint

Discretion Retained: USPTO Dodges Attack from Big Tech to Rein in Discretionary IPR Denials
November 22, 2021| Blog| Viewpoint

Who’s in Charge Here? Federal Circuit Says An Arbitrator, not District Court, Should Decide Arbitrability
November 22, 2021| Blog| Viewpoint

OSHA Vaccine Rule Blocked Permanently by Fifth Circuit, But Judicial Review Will Continue
November 19, 2021| Blog| Viewpoint

About Face: Laboratory-Developed Tests for COVID-19 Now Subject to EUA Requirements
November 19, 2021| Blog| Viewpoint

Mintz Lawyer’s New Book Puts 11 Faces on America’s Immigration ‘Crisis’
November 19, 2021| News

New York Significantly Expands its Whistleblower Law
November 19, 2021| Blog| Viewpoint

Examining Art Units to Avoid Subject Matter Eligibility Challenges for Bioinformatics and AI-related Patents
November 18, 2021| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
